Late Response to Anti-CGRP Monoclonal Antibodies in Migraine: A Multicenter, Prospective, Observational Study.
Sign Up to like & getrecommendations! Published in 2023 at "Neurology"
DOI: 10.1212/wnl.0000000000207292
Abstract: OBJECTIVES To assess frequency and characteristics of late responders (>12 weeks) to monoclonal antibodies (mAbs) targeting the calcitonin gene-related peptide (CGRP). METHODS This is a multicenter (n=16), prospective, real-life study, considering all consecutive adults with… read more here.
Keywords: multicenter prospective; cgrp mabs; late responders; monoclonal antibodies ... See more keywords